Heart transplantation immunosuppressive therapy

Jump to navigation Jump to search

Heart transplantation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Complications and Prognosis

Diagnosis

Indications

Evaluation

Contraindications

Criteria for Cardiac Transplantation

Equitable Distribution of Donor Hearts to those Awaiting Transplantation and the Process of Being Listed for a Transplant

Treatment

Medical Therapy

Surgery

Follow-Up

Electrocardiogram and Pacing After Cardiac Transplantation

Heart transplantation immunosuppressive therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heart transplantation immunosuppressive therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heart transplantation immunosuppressive therapy

CDC onHeart transplantation immunosuppressive therapy

Heart transplantation immunosuppressive therapy in the news

Blogs on Heart transplantation immunosuppressive therapy

Directions to Hospitals Treating Heart transplantation

Risk calculators and risk factors for Heart transplantation immunosuppressive therapy

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D.; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [1]

Immunosuppressive Therapy

Cyclosporine A

Cyclosporine Induced Hypertension

Hypertension occurs in 60% of patients on cyclosporine. The etiology is thought to be due to vasoconstriction. There is a loss of circadian rhythm in blood pressure. Verapamil, cardizem and nicardipine increase cyclosporine concentrations.

Adrenocortical steroids

Azathioprine

OKT3

Anti-thymocyte globulin (ATG)

References


Template:WikiDoc Sources